167 related articles for article (PubMed ID: 1540976)
1. The CySF-L2 factor from dialysable human leucocyte extract activates natural killer cytotoxicity by induction of interferon gamma.
Doelker I; Anderer FA
Cancer Immunol Immunother; 1992; 34(5):299-305. PubMed ID: 1540976
[TBL] [Abstract][Full Text] [Related]
2. A Viscum album oligosaccharide activating human natural cytotoxicity is an interferon gamma inducer.
Mueller EA; Anderer FA
Cancer Immunol Immunother; 1990; 32(4):221-7. PubMed ID: 2124513
[TBL] [Abstract][Full Text] [Related]
3. Dialysable factors from human leukocyte extracts activating human NK cytotoxicity against tumor cells: identification of factor-producing leukocyte subpopulations.
Neidlinger AC; Anderer FA
Anticancer Res; 1991; 11(6):2023-8. PubMed ID: 1776835
[TBL] [Abstract][Full Text] [Related]
4. Activation of antitumor cytotoxicity of human blood mononuclear cells by a basic factor from dialysable human-leukocyte extract.
Doelker I; Voetsch W; Anderer FA
Anticancer Res; 1989; 9(6):1915-20. PubMed ID: 2627139
[TBL] [Abstract][Full Text] [Related]
5. A dialysable acid factor from human leukocyte extracts activates tumor cell lysis mediated by human monocytes and natural killer cells.
Hamprecht KH; Vötsch W; Anderer FA
Onkologie; 1989 Jun; 12(3):120-7. PubMed ID: 2668834
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of bacillus Calmette-Guerin mediated natural killer cell activation.
Suttmann H; Jacobsen M; Reiss K; Jocham D; Böhle A; Brandau S
J Urol; 2004 Oct; 172(4 Pt 1):1490-5. PubMed ID: 15371877
[TBL] [Abstract][Full Text] [Related]
7. IL-12-mediated activation of MHC-unrestricted cytotoxicity of human PBMC subpopulations: synergic action of a plant rhamnogalacturonan.
Klein-Franke A; Anderer FA
Anticancer Res; 1995; 15(6B):2511-6. PubMed ID: 8669815
[TBL] [Abstract][Full Text] [Related]
8. Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells.
Ohkawa T; Seki S; Dobashi H; Koike Y; Habu Y; Ami K; Hiraide H; Sekine I
Immunology; 2001 Jul; 103(3):281-90. PubMed ID: 11454057
[TBL] [Abstract][Full Text] [Related]
9. Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer.
Baxevanis CN; Reclos GJ; Gritzapis AD; Dedousis GV; Missitzis I; Papamichail M
Cancer; 1993 Jul; 72(2):491-501. PubMed ID: 8319179
[TBL] [Abstract][Full Text] [Related]
10. Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15.
Dunne J; Lynch S; O'Farrelly C; Todryk S; Hegarty JE; Feighery C; Doherty DG
J Immunol; 2001 Sep; 167(6):3129-38. PubMed ID: 11544298
[TBL] [Abstract][Full Text] [Related]
11. Activation of human T cells with NK cell markers by staphylococcal enterotoxin A via IL-12 but not via IL-18.
Ami K; Ohkawa T; Koike Y; Sato K; Habu Y; Iwai T; Seki S; Hiraide H
Clin Exp Immunol; 2002 Jun; 128(3):453-9. PubMed ID: 12109440
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of stimulation of human natural killer cytotoxicity by arabinogalactan from Larix occidentalis.
Hauer J; Anderer FA
Cancer Immunol Immunother; 1993; 36(4):237-44. PubMed ID: 8439987
[TBL] [Abstract][Full Text] [Related]
13. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
Frey JR; Kamber M; Peck R
Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of IL-4 and IL-10 on IL-2-induced IFN-gamma synthesis and lymphokine-activated killer activity.
Hsu DH; Moore KW; Spits H
Int Immunol; 1992 May; 4(5):563-9. PubMed ID: 1627494
[TBL] [Abstract][Full Text] [Related]
15. Effect of Salmonella-infected human monocytes on natural killer cell cytotoxicity. In vitro studies.
Blanco L; Puente J; Carrasco C; Miranda D; Wolf ME; Mosnaim AD
Int Immunopharmacol; 2001 Jul; 1(7):1285-93. PubMed ID: 11460309
[TBL] [Abstract][Full Text] [Related]
16. An engineered anti-idiotypic antibody-derived killer peptide (KP) early activates swine inflammatory monocytes, CD3
Ferrari L; Martelli P; Saleri R; De Angelis E; Ferrarini G; Cavalli V; Passeri B; Bazzoli G; Ogno G; Magliani W; Borghetti P
Comp Immunol Microbiol Infect Dis; 2020 Oct; 72():101523. PubMed ID: 32758800
[TBL] [Abstract][Full Text] [Related]
17. Induction of NK-like activity in T cells by IL-2/anti-CD3 is linked to expression of a new antitumour receptor with specificity for acetylated mannose.
Zollner TM; Zhu HG; Anderer FA
Anticancer Res; 1993; 13(4):923-30. PubMed ID: 8352560
[TBL] [Abstract][Full Text] [Related]
18. The effect of anti-CD3 on the induction of non-MHC restricted cytolytic activity.
Watanabe H; Narumi K; Stewart CC; Arbuck SG; Foon KA; Goldrosen MH
Anticancer Res; 1992; 12(6B):1925-33. PubMed ID: 1295440
[TBL] [Abstract][Full Text] [Related]
19. Activation of human natural killer cells by lipopolysaccharide and generation of interleukin-1 alpha, beta, tumour necrosis factor and interleukin-6. Effect of IL-1 receptor antagonist.
Conti P; Dempsey RA; Reale M; Barbacane RC; Panara MR; Bongrazio M; Mier JW
Immunology; 1991 Aug; 73(4):450-6. PubMed ID: 1833315
[TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharide stimulates the proliferation of human CD56+CD3- NK cells: a regulatory role of monocytes and IL-10.
Goodier MR; Londei M
J Immunol; 2000 Jul; 165(1):139-47. PubMed ID: 10861046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
